» Articles » PMID: 23073954

Strategies to Help a Smoker Who is Struggling to Quit

Overview
Journal JAMA
Specialty General Medicine
Date 2012 Oct 18
PMID 23073954
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

Tobacco use is the leading preventable cause of death worldwide. Stopping tobacco use benefits virtually every smoker. Most of the 19% of US residents who smoke want to quit and have tried to do so. Most individual quit attempts fail, but two-thirds of smokers use no treatment when trying to quit. Treating tobacco dependence is one of the most cost-effective actions in health care. With a brief intervention, physicians can prompt smokers to attempt to quit and connect them to evidence-based treatment that includes pharmacotherapy and behavioral support (ie, counseling). Physicians can link smokers to effective counseling support offered by a free national network of telephone quit lines. Smokers who use nicotine replacement therapy (NRT), bupropion, or varenicline when trying to quit double their odds of success. The most effective way to use NRT is to combine the long-acting nicotine patch with a shorter-acting product (lozenge, gum, inhaler, or nasal spray) and extend treatment beyond 12 weeks. Observational studies have not confirmed case reports of behavior changes associated with varenicline and bupropion, and these drugs' benefits outweigh potential risks. A chronic disease management model is effective for treating tobacco dependence, which deserves as high a priority in health care systems as treating other chronic diseases like diabetes and hypertension.

Citing Articles

Evaluating the Effectiveness of Brief Interventions for Smoking Cessation Performed by Family Doctors.

Chirila S, Grasa C, Gurgas L, Cristurean C, Hanzu-Pazara L, Hangan T Medicina (Kaunas). 2025; 60(12.

PMID: 39768864 PMC: 11728199. DOI: 10.3390/medicina60121985.


Repeated participation in hospital smoking cessation services and its effectiveness in smoking cessation: a seven-year observational study in Taiwan.

Yang P, Chien Y, Luh D Arch Public Health. 2024; 82(1):241.

PMID: 39716266 PMC: 11667918. DOI: 10.1186/s13690-024-01452-9.


Tobacco cessation: screening and interventions.

Seo Y, Song S, Kang S, Kim S Korean J Fam Med. 2024; 46(1):12-19.

PMID: 39467847 PMC: 11824419. DOI: 10.4082/kjfm.24.0034.


Experiences of smoking and tobacco use during pregnancy: A qualitative study protocol.

Agras-Guardia M, Martinez-Torres S, Satue E, Granado-Font E, Palleja-Millan M, Patricio D PLoS One. 2024; 19(8):e0308781.

PMID: 39121101 PMC: 11315274. DOI: 10.1371/journal.pone.0308781.


Glucagon-like peptide-1 analogues: a new way to quit smoking? (SKIP)-a structured summary of a study protocol for a randomized controlled study.

Lengsfeld S, Burkard T, Meienberg A, Jeanloz N, Coynel D, Vogt D Trials. 2023; 24(1):284.

PMID: 37081574 PMC: 10120253. DOI: 10.1186/s13063-023-07164-9.


References
1.
Gunnell D, Irvine D, Wise L, Davies C, Martin R . Varenicline and suicidal behaviour: a cohort study based on data from the General Practice Research Database. BMJ. 2009; 339:b3805. PMC: 2755726. DOI: 10.1136/bmj.b3805. View

2.
. Quitting smoking among adults--United States, 2001-2010. MMWR Morb Mortal Wkly Rep. 2011; 60(44):1513-9. View

3.
Shiffman S, Ferguson S, Rohay J, Gitchell J . Perceived safety and efficacy of nicotine replacement therapies among US smokers and ex-smokers: relationship with use and compliance. Addiction. 2008; 103(8):1371-8. DOI: 10.1111/j.1360-0443.2008.02268.x. View

4.
Benowitz N . Smokeless tobacco as a nicotine delivery device: harm or harm reduction?. Clin Pharmacol Ther. 2011; 90(4):491-3. DOI: 10.1038/clpt.2011.191. View

5.
Schroeder S . A 51-year-old woman with bipolar disorder who wants to quit smoking. JAMA. 2009; 301(5):522-31. DOI: 10.1001/jama.2008.982. View